Continuous evidence.Between 3PAO assessments.

FedRAMP's annual penetration test is performed by an accredited 3PAO. Parameter runs the continuous monitoring side: testing every release, proving findings, and keeping the POA&M current between assessments, so the 3PAO starts from current, proven findings.

No. Parameter holds a SOC 2 Type I report with Type II underway. Whether and how a tool can test inside an authorized boundary is a question for your ISSO and 3PAO. The 3PAO's test must run in production; your own continuous testing can run against a staging environment that mirrors the boundary if that is what your ISSO allows.

ConMon asks for monthly scanning and a maintained POA&M. Parameter adds exploit-proven findings on every release, each tracked from open to verified fix, so the POA&M reflects real risk rather than scanner volume.

The guidance names six: external to corporate, external to CSP target system, tenant to CSP management system, tenant to tenant, mobile application to target system, and client-side application or agents to target system. Parameter covers the second, third, and fourth continuously, tested as different tenants. The first, fifth, and sixth stay with the 3PAO.

Yes. Every release is tested as it ships, so the security impact evidence for a change exists before the change request is filed.

The guidance itself says a penetration test should not be limited to automated scanning. Every Parameter finding ships with a working exploit and reproduction steps, which is the line between scanning and testing. The 3PAO still performs the annual test; this is what the POA&M shows in between.

3PAO penetration tests quoted on the market run from about $15,000 to $40,000 a year, on top of the assessment. Parameter is one annual contract scoped to the environment covered, for the continuous monitoring side, and it tests every release.